24/01139 Contract award, Instrument for extraction of DNA/RNA from viruses with consumables and service - FHI

es such as PCR and sequencing/NGS. The instrument is mainly intended for extraction of hepatitis virus, but other viruses may also be relevant. The extraction platform shall be particularly suitable for extraction of viruses (i.e. hepatitis A, B, C, D and E) from plasma and serum (in 2023 nucleic ac

id extraction was carried out by FHI of approx. 1,000 hepatitis virus samples; approx. 600 for RNA and 400 dna for further PCR analyses and sequencing/NGS, but the number will vary depending on the project and the number of samples submitte